Bioinformatics

Interdisciplinary Programs

Works Published in 2023

copy embed code
Copy Embed Code Experiment

You can embed this resource into your own website. To do so, either use the code generated by us, or use the link and tweak the rest to your preferences. Copy the respective code or link below.

Displaying all 8 works

Sorted by most recent date added to the index first, which may not be the same as publication date order.

2023 journal article

Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy

Cells.

By: G. Small, F. Akhtari, A. Green, T. Havener, M. Sikes, J. Quintanhila, R. Gonzalez, D. Reif ...

Source: ORCID
Added: June 8, 2023

2023 article

Utilizing Aggregated Molecular Phenotype (AMP) Scores to Visualize Simultaneous Molecular Changes in Mass Spectrometry Imaging Data

Chappel, J. R., King, M. E., Fleming, J., Eberlin, L. S., Reif, D. M., & Baker, E. S. (2023, June 5).

By: J. Chappel n, M. King*, J. Fleming n, L. Eberlin*, D. Reif & E. Baker*

Source: ORCID
Added: June 6, 2023

2023 article

A tiered testing strategy based on in vitro phenotypic and transcriptomic data for selecting representative petroleum UVCBs for toxicity evaluation in vivo

Tsai, H.-H. D., House, J. S., Wright, F. A., Chiu, W. A., & Rusyn, I. (2023, April 20). TOXICOLOGICAL SCIENCES.

By: H. Tsai*, J. House*, F. Wright, W. Chiu* & I. Rusyn*

author keywords: transcriptomic; petroleum; grouping; dose-response; HTTr; NAMs
Source: Web Of Science
Added: May 22, 2023

2023 journal article

MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

Pharmaceuticals.

By: R. Gonzalez*, G. Small*, A. Green n, F. Akhtari*, A. Motsinger-Reif*, J. Quintanilha*, T. Havener*, D. Reif, H. McLeod*, T. Wiltshire*

Source: ORCID
Added: May 19, 2023

2023 journal article

RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients

Pharmaceuticals.

By: R. Gonzalez*, G. Small*, A. Green n, F. Akhtari*, T. Havener*, J. Quintanilha*, A. Cipriani*, D. Reif ...

Source: ORCID
Added: May 12, 2023

2023 journal article

Legacy and emerging per- and polyfluoroalkyl substances suppress the neutrophil respiratory burst

JOURNAL OF IMMUNOTOXICOLOGY, 20(1).

By: D. Phelps, A. Palekar*, H. Conley, G. Ferrero*, J. Driggers, K. Linder, S. Kullman, D. Reif ...

author keywords: Innate immunity; neutrophils; per- and polyfluoroalkyl substances (PFAS); reactive oxygen species; zebrafish
Sources: ORCID, Web Of Science
Added: February 15, 2023

2023 article

Bayesian matrix completion for hypothesis testing

Jin, B., Dunson, D. B., Rager, J. E., Reif, D. M., Engel, S. M., & Herring, A. H. (2023, March 15). JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, Vol. 3.

By: B. Jin*, D. Dunson*, J. Rager*, D. Reif, S. Engel* & A. Herring*

author keywords: Bayesian hierarchical model; bioactivity profiles; chemical screening; heteroscedasticity; latent factor models; ToxCast; Tox21
Sources: ORCID, Web Of Science
Added: January 4, 2023

2023 journal article

TCDD alters essential transcriptional regulators of osteogenic differentiation in multipotent mesenchymal stem cells

Toxicological Sciences.

By: A. Watson n, A. Baez n, D. Jima n, D. Reif, J. Ding*, R. Roberts n, S. Kullman n

author keywords: mesenchymal stem cell; AhR; cell differentiation
Source: ORCID
Added: November 12, 2022